NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 50 of 59 results found.

Activity Company Description Location
Company 3i-Nano Activity: Research and Development Research and Development Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. Location Greensboro
Company AccuGenomics Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description AccuGenomics manufactures custom gene expression tests to diagnose and monitor cancer treatment. Its technologies include Standard Nucleic Acid Quantification for RNA and DNA Sequencing for any NGS platform analysis. Location Wilmington
Company AccuNovo Biotechnologies Inc. Activity: Research and Development Research and Development Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. Location Chapel Hill
Company Ad Astra Diagnostics Inc. Activity: Research and Development Research and Development Company Description Ad Astra Diagnostics develops rapid human health diagnostics and data systems. Location Morrisville
Company Aestas Pharma Inc. Activity: Research and Development Research and Development Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. Location Durham
Company Affinergy LLC Activity: Research and Development Research and Development Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. Location Durham
Company Appealing Products Inc. Activity: Research and Development Research and Development Company Description Appealing Products develops products for forensics and personal protection from toxic materials such as inorganics, gases and poisons in foods, animal feeds and liquids. Location Raleigh
Company Arcus-Med LLC Activity: Research and Development Research and Development Company Description Arcus-Med is developing software to diagnose pulmonary hypertension (PH). Location Raleigh
Company Atom Bioworks Inc. Activity: Research and Development Research and Development Company Description Atom Bioworks has developed a platform for programming DNA/RNA-based biomolecules as high-affinity binding reagents. Location Cary
Company Biofidelity Inc. Activity: Research and Development Research and Development Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. Location Morrisville
Company Bloodless Dx LLC Activity: Research and Development Research and Development Company Description Bloodless Dx is an assay development company focused on bloodless diagnostics. Location Apex
Company Cellex Inc. Activity: Research and Development Research and Development Company Description Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use. Location Cary
Company CellSolutions LLC Activity: Research and Development Research and Development Company Description CellSolutions develops liquid-based preparation and evaluation systems for cytology applications. The company's primary area of focus is women's health, including cervical cancer screening, precancer detection and evaluation of infectious disease. Location Greensboro
Company Cohesion Phenomics LLC Activity: Contract Research and Testing Contract Research and Testing Company Description Cohesion Phenomics is a CLIA-certified molecular diagnostic laboratory. Cohesion Phenomics also develops DNA sequencing tests for complex and single gene disorders within specific clinical areas such as cardiovascular disease. Location Spindale
Company Countervail Corp. Activity: Research and Development Research and Development Company Description Countervail is developing proprietary drug and diagnostic technologies to detect exposure to and prevent adverse effects from organophosphate pesticides. Location Mint Hill
Company Datar Cancer Genetics Activity: Research and Development Research and Development Company Description Datar Cancer Genetics develops blood-based diagnostics for early cancer detection and identifies personalized treatment strategies based on genomic and cellular analysis of a patient's cancer. Location Morrisville
Company Diabetic Health Inc. Activity: Research and Development Research and Development Company Description Diabetic Health develops coatings to improve the longevity and performance of continuous glucose monitoring sensors (CGM) and insulin infusion sets used in diabetes management. Location Research Triangle Park
Company Domus Diagnostics Activity: Research and Development Research and Development Company Description Domus Diagnostics is a point-of-care diagnostics company that develops accurate, rapid molecular tests for infectious diseases. Location Durham
Company Endacea Diagnostics Inc. Activity: Research and Development Research and Development Company Description Endacea Diagnostics is developing EndaTox IVD, an in vitro sepsis diagnostic, and EndaTox Test, an assay to measure LPS endotoxin in biological and non-biological samples. Location Research Triangle Park
Company Endacea Inc. Activity: Research and Development Research and Development Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. Location Research Triangle Park
Company Entegrion Inc. Activity: Research and Development Research and Development Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. Location Durham
Company EydisBio Inc. Activity: Research and Development Research and Development Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. Location Durham
Company Galaxy Diagnostics Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Galaxy Diagnostics offers advanced molecular and serology testing for hard-to-detect flea- and tick-borne infections. It serves physicians, veterinarians and clinical researchers. Location Durham
Company Gemelli Biotech Activity: Sales and Operations Sales and Operations Company Description Gemelli Biotech develops diagnostics and therapeutics for microbiome diseases. Location Raleigh
Company GeneCentric Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. Location Research Triangle Park
Company GeneType Activity: Research and Development Research and Development Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. Location Charlotte
Company Hemo Bioscience Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Hemo Bioscience is an FDA-registered, ISO 13485-accredited manufacturer of blood-typing reagents and diagnostics for the blood-banking industry. Location Durham
Company HIPRA Scientific USA LLC Activity: Research and Development Research and Development Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. Location Raleigh
Company Inanovate Inc. Activity: Research and Development Research and Development Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. Location Chapel Hill
Company Jericho Sciences LLC Activity: Research and Development Research and Development Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. Location Durham
Company Juno Metabolomics LLC Activity: Production and Manufacturing Production and Manufacturing Company Description Juno Metabolomics is developing next-generation metabolomics for precision medicine. Location Chapel Hill
Company Kalia Health Activity: Research and Development Research and Development Company Description Kalia Health develops home-based early detection tests for pregnancy complications like preeclampsia and eclampsia for use in low-resource settings. Location Chapel Hill
Company Lucerno Dynamics LLC Activity: Research and Development Research and Development Company Description Lucerno Dynamics is commercializing a medical device for quality control, dosimetry, and quality assurance for nuclear medicine. Future applications of the technology include rheumatoid arthritis, immunotherapy, and chemotherapy assessment. Location Cary
Company MDxHealth Inc. Activity: Research and Development Research and Development Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. Location Hillsborough
Company MIDAS Biotech LLC Activity: Research and Development Research and Development Company Description MIDAS Biotech develops in vitro diagnostic products. Location Morrisville
Company MultiSeq Inc. Activity: Research and Development Research and Development Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. Location Greensboro
Company NanoDiagnostic Technology LLC Activity: Research and Development Research and Development Company Description Nanodiagnostic Technology develops nanotechnology-based portable analytical devices for onsite rapid and sensitive detection of toxic chemical exposure, SARs-COV-2, and diseases at the point of care. Location Kannapolis
Company New Hope Biodiagnostics LLC Activity: Research and Development Research and Development Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. Location Chapel Hill
Company NIRvana Sciences Inc. Activity: Research and Development Research and Development Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. Location Research Triangle Park
Company OncoTAb Inc. Activity: Research and Development Research and Development Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. Location Charlotte
Company OrangeBiomed Inc. Activity: Sales and Operations Sales and Operations Company Description Orange Biomed is a healthcare startup developing diabetes management technology. Location Hillsborough
Company Path BioAnalytics Inc. Activity: Research and Development Research and Development Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. Location Durham
Company PETNET Solutions Inc. (Winston-Salem) Activity: Production and Manufacturing Production and Manufacturing Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. Location Winston-Salem
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) Activity: Production and Manufacturing Production and Manufacturing Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. Location Durham
Company Phenogen Sciences Inc. Activity: Sales and Operations Sales and Operations Company Description Phenogen Sciences provides predictive testing and risk assessment tools that help physicians proactively manage patient health. Location Charlotte
Company Precision Diabetes Inc. Activity: Sales and Operations Sales and Operations Company Description Precision Diabetes is developing a spectrum of unique diabetes tests, from detecting the risk of developing diabetes to diagnosing complications from diabetes. Location Cary
Company Quanticision Diagnostics Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Quanticision Diagnostics measures tissues biomarkers for solid tumor diagnosis and supplies multi-unit plates for high throughput immunoblot analysis. Location Research Triangle Park
Company Resonantia Diagnostics Activity: Research and Development Research and Development Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. Location Durham
Company Salvus LLC Activity: Research and Development Research and Development Company Description Salvus provides a handheld chemical and biological interferometric detector, a device which has the ability to rapidly identify chemicals, pathogens and viruses in liquid, air or surface environments. Location Charlotte
Company Sapere Bio Inc. Activity: Research and Development Research and Development Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. Location Research Triangle Park